Showing results (2631-2640 of 10,006) with videos related to

Sort By:
Pageof 1,001
Leukemia & Lymphoma|March 9, 2019
Complications and hospital costs during hematopoietic stem cell transplantation for non-Hodgkin lymphoma in the United StatesSang Kyu Cho, Jeffrey McCombs, Nathan Punwani, et al.
Leukemia & Lymphoma|January 22, 2021
The impact of cell-of-origin, MYC/Bcl-2 dual expression and MYC rearrangement on disease relapse among early stage diffuse large B-cell lymphoma patients treated with combined modality therapyAlexander Augustyn, L Jeffrey Medeiros, Ethan B Ludmir, et al.
Leukemia & Lymphoma|January 25, 2021
Results of a completely outpatient autologous stem cell transplant program for lymphoma patients receiving reduced-intensity conditioningJosé C Jaime-Pérez, Marcela Hernández-Coronado, Ernesto Picón-Galindo, et al.
Leukemia & Lymphoma|February 15, 2021
Sequential intensive chemotherapy followed by autologous or allogeneic transplantation for refractory lymphomaNina Orfali, Yuliya Jhanwar, Calvin Koo, et al.
Leukemia & Lymphoma|February 19, 2021
Validation of the composite organ and hematologic response model for prognostic prediction in a Chinese light chain amyloidosis cohortKai-Ni Shen, Hui-Lei Miao, Lu Zhang, et al.
Leukemia & Lymphoma|February 10, 2021
Searching for germline mutations in the RUNX1 gene among Polish patients with acute myeloid leukemiaAneta Bąk, Katarzyna Skonieczka, Anna Jaśkowiec, et al.
Leukemia & Lymphoma|March 3, 2021
Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naïve chronic lymphocytic leukemia: a phase 2 studySanjal Desai, Clifton Mo, Erika M Gaglione, et al.
Leukemia & Lymphoma|February 22, 2021
Randomized controlled trial of individualized, low dose, fixed duration lenalidomide maintenance versus observation after frontline chemo-immunotherapy in CLLNishant Jindal, Deepesh P Lad, Pankaj Malhotra, et al.
Leukemia & Lymphoma|February 11, 2021
MDMX/MDM4 is highly expressed and contributes to cell growth and survival in anaplastic large cell lymphomaVaios Sinatkas, Konstantina Stathopoulou, Ioanna Xagoraris, et al.
Leukemia & Lymphoma|March 8, 2017
Romidepsin is effective and well tolerated in older patients with peripheral T-cell lymphoma: analysis of two phase II trialsAndrei Shustov, Bertrand Coiffier, Steven Horwitz, et al.
Pageof 1,001